Related Experiment Video
Updated: Feb 7, 2026
11:28
Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
Published on: April 28, 2015
10.8K
Prussian Blue Nanozyme with Multienzyme Activity Reduces Colitis in Mice
Jiulong Zhao1, Xiaojun Cai2,3, Wei Gao3
1Department of Gastroenterology, Changhai Hospital , Second Military Medical University , 200433 Shanghai , P. R. China.
ACS Applied Materials & Interfaces
|July 21, 2018
Summary
Poly(vinylpyrrolidone)-modified Prussian blue (PPB) nanoparticles effectively scavenge reactive oxygen species (ROS) and reduce inflammation. This novel nanomedicine shows promise for treating inflammatory bowel disease (IBD) in animal models with minimal side effects.
Area of Science:
- Biomedical Engineering
- Nanomedicine
- Inflammation Research
Background:
- Reactive oxygen species (ROS) overproduction is a key factor in inflammatory bowel disease (IBD) progression.
- Prussian blue (PB) nanoparticles function as nanozymes that can scavenge ROS.
- PB-based nanomaterials have not been explored for IBD treatment.
Purpose of the Study:
- To develop and evaluate poly(vinylpyrrolidone)-modified Prussian blue (PPB) nanoparticles for IBD treatment.
- To assess the ROS scavenging and anti-inflammatory capabilities of PPB nanoparticles in vivo.
- To demonstrate the therapeutic potential of PB-based nanomedicine for IBD.
Main Methods:
- Construction of poly(vinylpyrrolidone)-modified Prussian blue (PPB) nanoparticles using a simple and efficient method.
- Evaluation of PPB nanoparticle physiological stability and biosafety.
- Intravenous administration of PPB nanoparticles to mice with induced colitis to assess therapeutic effects.
Main Results:
- Prepared PPB nanoparticles exhibited good physiological stability and biosafety.
- PPB nanoparticles effectively scavenged ROS and inhibited pro-inflammatory cytokines.
- Significant reduction in colitis severity was observed in mice treated with PPB nanoparticles.
- No distinct side effects were noted following intravenous administration of PPB nanoparticles.
Conclusions:
- Poly(vinylpyrrolidone)-modified Prussian blue nanoparticles represent a promising nanomedicine for IBD treatment.
- PB-based nanomedicine demonstrates significant protective effects against colitis in a murine model.
- This study offers a potential alternative therapeutic strategy for patients suffering from IBD.
More Related Videos
Related Concept Videos
01:18Reducing Line Loss
390
In a three-phase circuit, line loss is an indicator of energy dissipated as heat due to the resistance of transmission lines. To address this, incorporating transformers into the system—a step-up transformer at the source and a step-down transformer at the load—is a strategic solution. Two three-phase transformers are introduced to improve this.
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
390
01:22Methods of reducing fever
1.4K
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
1.4K
01:29Drugs for Treatment of Ulcerative Colitis in IBD
527
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
527
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
1.0K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.0K
01:57Adaptations that Reduce Water Loss
28.2K
Though evaporation from plant leaves drives transpiration, it also results in loss of water. Because water is critical for photosynthetic reactions and other cellular processes, evolutionary pressures on plants in different environments have driven the acquisition of adaptations that reduce water loss.
28.2K
01:29Role of Reduced Coenzymes NADH and FADH₂
16.9K
The energy released from the breakdown of the chemical bonds within nutrients can be stored either through the reduction of electron carriers or in the bonds of adenosine triphosphate (ATP). In living systems, a small class of compounds functions as mobile electron carriers, molecules that bind to and shuttle high-energy electrons between compounds in pathways. The principal electron carriers that will be considered originate from the B vitamin group and are derivatives of nucleotides; they are...
16.9K